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Abstract
Introduction
High-quality  epidemiologic  research  is  essential  in 
reducing chronic diseases. We analyzed the quality of sys-
tematic reviews of observational nontherapeutic studies.
Methods
We searched several databases for systematic reviews of 
observational nontherapeutic studies that examined the 
prevalence of or risk factors for chronic diseases and were 
published in core clinical journals from 1966 through June 
2008. We analyzed the quality of such reviews by using 
prespecified criteria and internal quality evaluation of the 
included studies.
Results
Of  the  145  systematic  reviews  we  found,  fewer  than 
half met each quality criterion; 49% reported study flow, 
27% assessed gray literature, 2% abstracted sponsorship 
of individual studies, and none abstracted the disclosure 
of conflict of interest by the authors of individual studies. 
Planned,  formal  internal  quality  evaluation  of  included 
studies was reported in 37% of systematic reviews. The 
journal of publication, topic of review, sponsorship, and 
conflict of interest were not associated with better qual-
ity. Odds of formal internal quality evaluation (odds ratio 
[OR], 1.10 per year; 95% confidence interval [CI], 1.02-1.19) 
and either planned, formal internal quality evaluation or 
abstraction of quality criteria of included studies (OR, 1.17 
per year; 95% CI, 1.08-1.26) increased over time, without 
positive trends in other quality criteria from 1990 through 
June 2008. Systematic reviews with internal quality eval-
uation did not meet other quality criteria more often than 
those that ignored the quality of included studies.
Conclusion
Collaborative efforts from investigators and journal editors 
are needed to improve the quality of systematic reviews.
Introduction
Valid epidemiologic research is essential in preventing 
chronic diseases (1-3). Assessing the quality of observa-
tional studies is an important part of evidence synthesis 
(4). Systematic reviews have become key tools in evidence 
synthesis from a growing number of epidemiologic studies 
(5). Producing high-quality systematic reviews is essential 
to  developing  generalizable  and  actionable  conclusions 
(6,7).  Quality  criteria  for  systematic  reviews  have  been 
proposed  by  working  groups  that  developed  the  Meta- 
analysis  of  Observational  Studies  in  Epidemiology 
(MOOSE), Strengthening the Reporting of Observational 
Studies  in  Epidemiology  (STROBE),  and  a  measure-
ment  tool  for  assessment  of  multiple  systematic  reviews 
(AMSTAR) (8-12). The working groups and the Cochrane 
handbook  (13)  addressed  those  criteria  for  systematic 
reviews that more likely result in biased results, including 
bias in selection of the studies or the information within 
studies by the reviewers (14-18) or bias in the publication 
of positive significant results (6,15,19,20).
Previous  research  and  guidelines  (13,21-23)  focus  on 
systematic  reviews  of  interventional  therapeutic  studies. 
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Validity of observational nontherapeutic studies of preva-
lence  of  chronic  diseases  or  risk  factors  for  diseases  is 
essential  for  effective  preventive  public  health  actions 
(24,25). Our aim was to evaluate the quality of system-
atic reviews of observational nontherapeutic studies that 
examined the incidence and prevalence of chronic condi-
tions and risk factors for diseases. The criteria we used 
to  determine  the  reporting  and  methodologic  quality  in 
systematic reviews were from published standards (8-12). 
We hypothesized that the quality of systematic reviews 
differs  by  the  time  when  the  study  was  published,  the 
country in which the study was conducted, the journal of 
publication, the sponsorship of the study, and whether a 
conflict  of  interest  was  disclosed.  We  hypothesized  also 
that systematic reviews with internal quality evaluation 
of the included studies would have better quality, demon-
strating commitment to quality of evidence.
Methods
Data sources
We  searched  MEDLINE  via  PubMed  and  via  Ovid 
MEDLINE, the Cochrane Library (26) and working groups, 
WorldCat (27), and Scirus (28) to find systematic reviews of 
observational nontherapeutic studies published in English 
from  1966  through  June  2008  in  core  clinical  journals 
(exact search string is listed in Appendix Table 1). We used 
the definitions of core clinical journals from the Abridged 
Index Medicus (119 indexed titles). We defined observa-
tional  nontherapeutic  studies  as  observations  of  patient 
outcomes that did not examine procedures concerned with 
the remedial treatment or prevention of diseases (29).
Study selection
Three  investigators  independently  decided  on  the  eli-
gibility  of  the  studies  according  to  recommendations 
from the Cochrane Handbook for Systematic Reviews of 
Interventions (13). We reviewed abstracts to exclude com-
ments, expert opinions, letters, case reports, systematic 
reviews of interventional studies, and systematic reviews 
of studies of diagnostic accuracy of tests.
Data extraction
Evaluations  of  the  studies  and  data  extraction  were 
performed  independently  by  2  researchers.  Predefined   
categorical responses to the checklist items were abstract-
ed into our spreadsheet. Errors in data extraction were 
assessed  by  a  comparison  of  the  data  charts  with  the 
original articles (13,30). Any discrepancies were discussed 
and resolved. The quality criteria that we abstracted were 
based  on  guidelines  for  determining  the  reporting  and 
methodologic quality of systematic reviews (8-12).
To evaluate selection bias, we abstracted whether the 
authors of systematic reviews described the search strat-
egy (yes, no, or partially); yes indicated that the authors 
reported time periods of searches, searched databases, and 
exact search string. We abstracted whether the authors 
of  systematic  reviews  described  study  flow  (yes,  no,  or 
partially); yes indicated that the authors reported the list 
of retrieved citations, the list of excluded studies, and jus-
tification for exclusion.
We  abstracted  as  dichotomous  variables  whether  the 
authors of systematic reviews did any of the following:
• Stated the aim of the review and the primary and sec-
ondary hypotheses of the review.
• Included or justified exclusion of articles published in 
languages other than English.
• Searched  for  gray  literature,  including  abstracts  and 
unpublished studies, to evaluate publication bias (21).
• Described  any  contact  with  authors  of  the  included   
studies.
• Analyzed sponsorship of and conflict of interest in the 
included studies.
We abstracted how the authors of systematic reviews 
described obtained statistical methods with justification 
and models for pooling with fixed or random effects models 
in sufficient detail to be replicated (no pooling, random, 
or fixed). We abstracted whether the authors of pooling 
analyses reported statistical tests for heterogeneity and 
whether  heterogeneity  was  statistically  significant  (not 
reported, not significant, or significant).
We used 3 categories to classify whether the authors of 
systematic reviews had evaluated the quality of included 
studies by using developed or previously published check-
lists or scales (31): 1) the authors stated planned, formal 
internal  quality  evaluations;  2)  the  authors  abstracted 
selected criteria of external or internal validity without 
using  a  planned,  formal,  and  comprehensive  internal 
quality  evaluation;  and  3)  the  authors  did  not  conduct VOLUME 7: NO. 6
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internal quality evaluations. We further categorized the 
studies that evaluated quality criteria to compare stud-
ies with no mention of internal quality evaluation of the 
included  studies.  We  also  compared  studies  with  and 
without planned formal internal quality evaluation. We 
abstracted with dichotomous responses blinding and reli-
ability testing (reported or not reported) of internal quality 
evaluations.
We abstracted several explanatory variables that could 
be related to the quality of systematic reviews:
• The year of publication, defined as a continuous vari-
able. We created categories of 4- or 5-year periods: 1990 
to 1994, 1995 to 1999, 2000 to 2004, and 2005 through 
June 2008.
• The journals of publication.
• The  country  where  the  systematic  reviews  were   
performed.
• The sponsorship of the reviews. Those that had either 
governmental  or  foundational  support  or  were  fellow-
ships were defined as having nonprofit support.
• The disclosure of conflict of interest by authors of reviews 
(either not disclosed, disclosed as no conflict of interest, 
or disclosed conflict of interest).
• The  number  of  disclosed  relationships  with  industry, 
defined as a continuous variable.
• The sponsor’s participation in data collection, analysis, 
and interpretation of the results of the review.
• The review outcomes as risk factors for prevalence or 
incidence of chronic conditions or diseases.
Data synthesis
We summarized the results in evidence tables. We used 
prespecified  categories  of  dependent  and  independent 
variables and did not force the data into binary categories 
for  definitive  tests  of  significance.  We  used  univariate 
logistic  regression  to  examine  the  association  between 
internal quality evaluation and the year of the publica-
tion  by  using  the  Wald  test.  Odds  ratios  (ORs)  were 
calculated with binary logit models and Fisher’s scoring 
method technique. We computed the fractions of system-
atic reviews meeting various quality criteria in each of the 
4 time periods considered. The proportions of systematic 
reviews that met different levels of each quality criterion 
were evaluated by using χ2 tests and Fisher’s exact tests 
in cases of small numbers. All calculations were performed 
at 95% confidence intervals (CIs) by using 2-sided P values 
with SAS version 9.1.3 (SAS Institute, Inc, Cary, North 
Carolina).
Results
We found 145 eligible systematic reviews of observational 
nontherapeutic studies (study flow in the Appendix Figure) 
(32-176).  The  number  of  published  systematic  reviews 
increased  from  17  during  1990-1994  to  56  during  2005-
2008. Most of the studies were conducted in the United 
States (55 publications) or in the United Kingdom (28 pub-
lications) (Appendix Table 2). Half of the systematic reviews 
(73 publications) were funded by nonprofit organizations; 
56 (39%) reviews did not publish their funding sources, 4 
reviews received industry support, and 10 were sponsored 
jointly  by  industry  and  nonprofit  organizations.  Almost 
three-fourths  (106)  of  the  authors  of  systematic  reviews 
did not disclose conflict of interest; 35 publications stated 
that the authors do not have any conflict of interest; and 4 
studies were conducted by authors who reported conflict of 
interest. The studies were published in 49 journals. Most 
systematic reviews (122 studies) assessed risk factors for 
chronic diseases, 19 summarized estimates of prevalence 
or incidence, 2 studies reported prevalence and associations 
with risk factors, and 2 studies examined levels of risk fac-
tors. Most studies reported incidence and risk factors for 
cardiovascular diseases (46 studies) or cancer (26 studies).
Quality of systematic reviews
Less than half of the studies reported study flow (49%), 
assessed gray literature (27%), or addressed language bias 
(29%) (Table 1). Only 2% of reviews abstracted sponsorship 
of individual studies and none abstracted the disclosure of 
conflict  of  interest  by  the  authors  of  individual  studies 
that were eligible for the reviews. Pooling was performed 
in 137 studies; of these, 62% used a random effects model; 
57%  reported  detecting  significant  heterogeneity  across 
the  studies;  and  19%  did  not  provide  any  information 
about  statistical  heterogeneity  in  pooled  estimates.  The 
proportion of systematic reviews that met quality criteria 
including  study  flow,  assessment  of  gray  literature,  or 
the abstraction of funding sources of included studies did 
not show significant trends from 1990 through 2008. The 
proportion of systematic reviews that assessed language 
bias increased from 8% during 1995-1999 to 41% during 
2005-2008. In later years, more studies reported using ran-
dom effects models (79% during 2005-2008 vs 39% during   VOLUME 7: NO. 6
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1995-1999)  and  tests  for  statistical  heterogeneity  (89% 
during 2005-2008 vs 65% during 1995-1999).
Internal quality evaluation
Planned  and  detailed  quality  assessment  of  included 
studies was reported in 37% of systematic reviews, and 
18%  abstracted  more  than  1  criterion  of  external  or 
internal quality; significant positive trends were reported 
during the evaluated time (Table 1). Quality assessment 
was masked in 3 studies. Development of the appraisals, 
including  references  to  previously  published  tools,  was 
reported  in  32  studies,  but  only  6  tested  interobserver 
agreement for quality assessment.
Quality of systematic review by explanatory factors
The quality of systematic reviews did not differ much by 
study location or by the journal of publication. Systematic 
reviews of prevalence or incidence or risk factors of the dis-
eases did not differ in their quality measures. Sponsorship 
was not associated with quality of the reviews. The role of 
conflict of interest was impossible to establish because the 
authors of 56 reviews did not disclose funding and authors 
of 106 reviews did not disclose conflict of interest.
Explanatory factors of internal quality evaluation of includ-
ed studies
The  journal  of  publication,  topic  of  the  review,  and 
continent  where  the  review  was  conducted  were  not 
associated with the likelihood of internal quality evalua-
tion. Systematic reviews of risk factors tended to conduct 
internal quality evaluation of the included studies more 
often than reviews of incidence or prevalence or of levels 
of risk factors. Systematic reviews sponsored by nonprofit 
organizations  conducted  internal  quality  evaluations  of 
individual studies more often than reviews that received 
corporate  funding.  Systematic  reviews  that  disclosed 
conflict of interest conducted internal quality evaluation 
of  individual  studies  less  frequently  (10  of  39  studies; 
26%) than reviews with no disclosure (44 of 106 studies; 
42%). Odds of formal internal quality evaluation (OR, 1.10 
per year; 95% CI, 1.02-1.19) and either planned, formal 
internal quality evaluation or abstraction of quality crite-
ria (OR, 1.17 per year; 95% CI, 1.08-1.26) increased over 
time. Disclosure of conflict of interest by the authors of 
systematic reviews was not associated with greater odds 
of internal quality evaluation.
Quality of systematic reviews by internal quality evaluation
Complete documentation of the literature search includ-
ing time period, databases searched, and exact literature 
search  strings  was  less  common  among  reviews  with 
planned, formal internal quality evaluation (48 studies, 
35%)  than  among  reviews  without  it  (90  studies,  65%) 
(Table 2). However, reviews that either abstracted selected 
quality criteria or planned, formal internal quality evalu-
ation reported partial (6 studies) or complete (74 studies) 
information about the literature search more often than 
studies  that  did  not  evaluate  quality  of  included  stud-
ies (64 studies). Reviews that did not justify exclusion of 
non-English studies ignored quality of individual studies 
more often (72 studies) than reviews with planned, formal 
internal quality evaluation (31 studies). The same pattern 
was present for publication bias: the reviews that did not 
mention gray literature also ignored the quality of indi-
vidual studies. The reviews reporting attempts to contact 
the authors of included studies either performed planned, 
formal internal quality evaluation or abstracted selected 
quality  criteria  more  often  than  reviews  without  such 
attempts (OR, 2.3; 95% CI, 1.1-4.7). Reviews with com-
plete reporting of study flow performed planned, formal 
internal quality evaluation or abstracted quality criteria 
more often (51 studies) than reviews without study flows 
(20 studies). More than half of systematic reviews without 
planned, formal internal quality evaluation (44 studies) 
also did not report study flow.
The association between quality of systematic reviews 
and sponsor participation in the data collection, analyses, 
and interpretation was difficult to analyze because this 
information  was  either  omitted  or  reported  in  various 
ways. Less than 10% of systematic reviews contained a 
clear statement that the sponsors did not play any role 
in gathering the studies or analyzing or interpreting the 
results  and  did  not  influence  the  content  of  the  manu-
script. Other reviews omitted mention of the role of the 
sponsor in approval of the manuscript or provided a gen-
eral statement that sponsors did not influence the conclu-
sions or the content of the paper. Two reviews included 
statements of unconditional or unrestricted sponsorship of 
the meta-analyses.
Discussion
Our  analyses  showed  that  less  than  half  of  the   VOLUME 7: NO. 6
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systematic  reviews  of  nontherapeutic  observational 
studies that were published in core clinical journals met 
each quality criterion. Quality of systematic reviews did not 
improve over time. Planned, formal internal quality evalu-
ations of the included studies was reported in less than 
half of systematic reviews, but the prevalence of internal 
quality evaluations has increased during the last decade. 
Our findings are in concordance with previously published 
methodologic  analyses  of  systematic  reviews  that  also 
found inconsistent quality and incomplete internal quality 
evaluation of individual studies (6). Methodologic analyses 
of systematic reviews that focused on particular diseases 
or conditions demonstrated that half of the publications 
had  major  flaws  in  design  and  reporting.  For  instance, 
systematic reviews of therapies for renal diseases failed to 
assess the methodologic quality of included studies (177). 
Methodologic analyses of systematic reviews of interven-
tions  showed  that  69%  of  those  randomly  selected  in 
MEDLINE meta-analyses did not analyze quality of trials 
(22). Most (68%) systematic reviews of diagnostic tests for 
cancer did not provide formal assessments of study qual-
ity (178). We also found that the quality of reviews did not 
differ among types of studies (incidence or risk factors for 
diseases), types of diseases, or journal of publication.
Journal commitment to high-quality research, however, 
was  associated  with  improved  reporting  quality  of  the 
publications.  For  example,  adoption  by  journals  of  the 
Consolidated Standards of Reporting Trials (CONSORT) 
improved  the  quality  of  the  publications  of  interven-
tional studies (179,180). An endorsement of the developed 
standards  for  observational  studies  including  MOOSE 
and STROBE checklists may also improve quality of the 
publications. We did not analyze how many core clinical 
journals adopted these standards and how quality of the 
publications changed depending on this adaptation. Peer 
review of submitted manuscripts should include quality 
assessment using validated tools (12).
We could not identify the factors that can explain dif-
ferences  in  quality  of  systematic  reviews.  The  role  of 
sponsorship and conflict of interest could not be estimated 
because of poor reporting of this information. The quality 
and reliability of quality evaluation of the included stud-
ies is unclear because development of the appraisals was 
described in a small proportion of systematic reviews (32 
of 80 studies), and only 6 of 80 studies tested interobserver 
agreement for quality assessment. We did not evaluate 
all reviews of observational studies that were published 
in epidemiologic journals. However, it is unlikely that the 
quality of reviews published in other journals would be 
better than those in core clinical journals. Future research 
should investigate the factors that can explain differences 
in the quality of systematic reviews.
Peer  reviewed  publications  of  high-quality  systematic 
reviews can provide the best available research evidence 
for  evidence-based  public  health  (24).  Evidence-based 
decisions can improve public health practice in prevent-
ing incidence and progression of chronic diseases (25). In 
our analysis, less than half of the systematic reviews of 
observational  nontherapeutic  studies  met  quality  crite-
ria established in the MOOSE, STROBE, and AMSTAR 
statements. Internal quality evaluation of included studies 
should be an essential part of evidence synthesis, but only 
half of the reviews reported such evaluation. Collaborative 
efforts from investigators and journal editors are needed to 
improve quality of systematic reviews.
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Tables
Table 1. Quality Criteria of Systematic Reviews of Observational Nontherapeutic Studies Published in Core Clinical Journals, by Year 
of Publication, 1990 Through June 2008
Evaluated Criteria
1990-1994, 
n 
(N = 17)
1995-1999, 
n 
(N = 26)
2000-2004, 
n 
(N = 46)
2005-2008, 
n 
(N = 56)
Total, 
n 
(N = 145) P Valuea
Literature search
No information 0 0 1 0 1
.7
Documented partially 1 1  1 6
Complete documenting of databases used, exact 
search strings used, and time periods of searches
16 25 2 55 1
Contact with authors of the included studies
No information 1 17 1 1 92
. The authors of the review attempted to contact the 
authors of included studies
 9 15 25 5
Study flow
Study flow not reported 10 15 29 1 72
.0
Study flow partially reported 0 0 0 2 2
Study flow reported with the list of retrieved cita-
tions, the list of excluded studies, and justification 
for exclusion for each study
7 11 17 6 71
Articles published in languages other than English
Language bias was not addressed 15 2 1  10
.01 Language bias was addressed: the authors included 
or justified exclusion of the non-English publications
2 2 15 2 2
Gray literature
Gray literature was not assessed 15 17 6  106
.25 Reporting of the method of handling abstracts and 
unpublished studies
2 9 10 1 9
Conflict of interest from included studies
Conflict of interest in included studies was not 
abstracted
17 26 6 56 15
NA
Sponsorship of the included studies
Sponsorship of included studies was not analyzed 16 25 6 55 12
.5
Sponsorship of included studies was analyzed 1 1 0 1 
 
Abbreviation: NA, not applicable.  
a P values for overall χ2 test.
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Evaluated Criteria
1990-1994, 
n 
(N = 17)
1995-1999, 
n 
(N = 26)
2000-2004, 
n 
(N = 46)
2005-2008, 
n 
(N = 56)
Total, 
n 
(N = 145) P Valuea
Pooled model obtained in the review
Pooling was not obtained 2 0  2 
<.001
Fixed effects model was obtained for meta-analyses 10 16 11 10 7
Random effects model was obtained for meta- 
analyses
5 10 1  90
Heterogeneity across included studies
Heterogeneity across studies was not reported 6 9 7 6 2
.0 Heterogeneity across studies was not significant 5 6 1 11 5
Heterogeneity across studies was significant 6 11 26 9 2
Formal internal quality evaluation of included studies
Planned, formal internal quality evaluation with 
developed or previously published checklists or 
scales
 6 20 25 5
<.001 Some selected criteria of external or internal quality 
of included studies were abstracted without planned, 
formal internal quality evaluation
2  1 20 26
No internal quality evaluation 12 17 25 11 65
Reliability of internal quality evaluation reported 2   1 2 .99
Internal quality evaluation was masked 1 1 0 1  .11
 
Abbreviation: NA, not applicable.  
a P values for overall χ2 test.
Table 2. Quality of Systematic Reviews, by Internal Quality Evaluation of Included Studies, 1990 Through June 2008
Quality Criterion
Definition of Formal Internal Quality Evaluation
Planned, Formal 
Internal Quality 
Evaluation or 
Abstraction of Some 
Quality Criteria, n
Neither Planned, 
Formal Internal 
Quality Evaluation 
nor Abstraction 
of Some Quality 
Criteria, n
Planned, Formal 
Internal Quality 
Evaluation, n
No Planned, Formal 
Internal Quality 
Evaluation, n
Literature search P = .0a P = .00b
No information 0 1 0 1
Documented partially 6 0 6 0
 
a P value for overall χ2 test between planned, formal internal quality evaluation or abstraction of some quality criteria versus neither planned, formal internal 
quality evaluation nor abstraction of some quality criteria. 
b P value for overall χ2 test between planned, formal internal quality evaluation versus no planned, formal internal quality evaluation.
Table 1. (continued) Quality Criteria of Systematic Reviews of Observational Nontherapeutic Studies Published in Core Clinical 
Journals, by Year of Publication, 1990 Through June 2008
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Quality Criterion
Definition of Formal Internal Quality Evaluation
Planned, Formal 
Internal Quality 
Evaluation or 
Abstraction of Some 
Quality Criteria, n
Neither Planned, 
Formal Internal 
Quality Evaluation 
nor Abstraction 
of Some Quality 
Criteria, n
Planned, Formal 
Internal Quality 
Evaluation, n
No Planned, Formal 
Internal Quality 
Evaluation, n
Complete documenting of databases used, exact 
search strings used, and time periods of searches
7 6  90
Contact with authors of the included studies P = .02a P = .25b
No information   1 61
The authors of the review attempted to contact the 
authors of included studies
6 17 2 0
Study flow P < .001a P = .00b
Study flow not reported 2  17 55
Study flow partially reported 1 1 1 1
Study flow reported with the list of retrieved citations, 
the list of excluded studies, and justification for exclu-
sion for each study
51 20 6 5
Articles published in languages other than English P = .001a P = .01b
No information  55 1 72
Inclusion of non-English studies or justification for 
exclusion
2 10 2 19
Gray literature P = .09a P = .0b
No information 5 52  72
Reporting of the method of handling abstracts and 
unpublished studies
26 1 20 19
Conflict of interest from included studies
No information 0 65 5 91
Sponsorship of the included studies P = .a P = .1b
No information 79 6 5 
Sponsorship of included studies was abstracted 1 2 0 
Pooled model obtained in the review P < .001a  P = .06b 
Not applicable (no pooling) 6 2 5 
Fixed effects model 15 2 12 5
Random effects model 59 1 7 5
 
a P value for overall χ2 test between planned, formal internal quality evaluation or abstraction of some quality criteria versus neither planned, formal internal 
quality evaluation nor abstraction of some quality criteria. 
b P value for overall χ2 test between planned, formal internal quality evaluation versus no planned, formal internal quality evaluation.
Table 2. (continued) Quality of Systematic Reviews, by Internal Quality Evaluation of Included Studies, 1990 Through June 2008
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Quality Criterion
Definition of Formal Internal Quality Evaluation
Planned, Formal 
Internal Quality 
Evaluation or 
Abstraction of Some 
Quality Criteria, n
Neither Planned, 
Formal Internal 
Quality Evaluation 
nor Abstraction 
of Some Quality 
Criteria, n
Planned, Formal 
Internal Quality 
Evaluation, n
No Planned, Formal 
Internal Quality 
Evaluation, n
Heterogeneity across included studies P = .27a P = .67b
Not reported 1 15 9 19
Heterogeneity was not significant 17 1 15 20
Heterogeneity was significant at least for one  
association
50 2 0 52
 
a P value for overall χ2 test between planned, formal internal quality evaluation or abstraction of some quality criteria versus neither planned, formal internal 
quality evaluation nor abstraction of some quality criteria. 
b P value for overall χ2 test between planned, formal internal quality evaluation versus no planned, formal internal quality evaluation.
Appendix
Table 1. Search Strategy and Exact Search Strings Used to Identify Systematic Reviews of Observational Studies, Scales and 
Checklists for Internal Quality Evaluation, and Studies About Bias in Observational Research, 1966 Through June 2008
Search Method No. of Articles Identified
Search strategy for Ovid MEDLINE
1. exp Research Design/st [Standards] ,0
2. exp Chronic Disease/ep [Epidemiology] 1,619
. exp Urinary Incontinence/ep [Epidemiology] 1,155
. exp Fecal Incontinence/ep [Epidemiology] 2
5. exp “Sleep Initiation and Maintenance Disorders”/ep [Epidemiology] 565
6. exp Depression/ep [Epidemiology] ,700
7. exp Depressive Disorder/ep [Epidemiology] 6,16
. exp Myocardial Infarction/ ,51
9. 6 or 7 11,21
10.  and 9 105
11. 2 or  or  or 5 or 10 ,66
12. 1 and 11 9
1. exp Data Collection/mt, st [Methods, Standards] 6,17
1. exp “Bias (Epidemiology)”/ 25,69
 
Abbreviations: MeSH, Medical Subject Heading term; sb, subset; CN, corporate author.
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Search Method No. of Articles Identified
Search strategy for Ovid MEDLINE (continued)
15. exp Questionnaires/st [Standards] ,79
16. exp Evidence-Based Medicine/ 27,7
17. 1 or 1 or 15 or 16 6,57
1. 11 and 17 127
19. 12 or 1 1
20. limit 19 to english language 12
21. exp “Predictive Value of Tests”/ 62,290
22. exp “Reproducibility of Results”/ 126,75
2. 21 or 22 12,91
2. 11 and 2 126
25. limit 2 to english language 121
26. 20 or 25 22
27. exp randomized controlled trial/ 151,027
2. 11 and 27 7
29. exp research design/ 1,6
0. 2 and 29 15
1. 1 and 16 57
2. ep.fs. ,92
. exp epidemiology/ 6,500
. 2 or  7,7
5. 1 and  29
6. exp incidence/ 1,260
7. exp prevalence/ ,71
. 6 or 7 157,29
9. 1 and  1
0. 26 or 0 or 5 or 9 26
1. limit 0 to english language 267
2. limit 1 to journal article 251
. from 2 keep 1-251 251
 
Abbreviations: MeSH, Medical Subject Heading term; sb, subset; CN, corporate author.
Appendix Table 1. (continued) Search Strategy and Exact Search Strings Used to Identify Systematic Reviews of Observational 
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Search Method No. of Articles Identified
MEDLINE search via PubMed
(“Biomedical Research/methods”[MeSH] OR “Biomedical Research/organization and 
administration”[MeSH] OR “Biomedical Research/standards”[MeSH] OR “Biomedical Research/statistics 
and numerical data”[MeSH] OR “Biomedical Research/trends”[MeSH]) Limits: Humans, Journal Article, 
English
,70
“Epidemiologic Studies”[MeSH] AND “Research Design/standards”[MeSH] AND (“Evaluation Studies as 
Topic/classification”[MeSH] OR “Evaluation Studies as Topic/methods”[MeSH] OR “Evaluation Studies as 
Topic/standards”[MeSH]) Limits: Humans, Journal Article, English
59
“Publishing/standards”[MeSH] AND “Epidemiologic Methods”[MeSH] AND “Research Design/
standards”[MeSH] Limits: Humans, Journal Article, English
65
“STROBE Initiative”[Corporate Author] 10
“Bias (Epidemiology)”[MeSH] AND “Epidemiologic Studies”[MeSH] AND “Epidemiologic Methods”[MeSH] 
AND “Research Design/standards”[MeSH] Limits: Humans, Journal Article, English
97
“Evidence-Based Medicine”[MeSH] AND “Epidemiologic Studies”[MeSH] AND ”Epidemiologic 
Methods”[MeSH] AND “Research Design/standards”[MeSH] Limits: Humans, Journal Article, English
25
“Research Design/standards”[MeSH] AND “Epidemiologic Studies”[MeSH] AND “Epidemiologic 
Measurements”[MeSH] AND “Bias (Epidemiology)”[MeSH] Limits: Humans, Journal Article, English AND 
“Incidence”[MeSH] Limits: Humans, Journal Article, English

“Research Design/standards”[MeSH] AND “Epidemiologic Studies”[MeSH] AND “Epidemiologic 
Measurements”[MeSH] AND “Bias (Epidemiology)”[MeSH] Limits: Humans, Journal Article, English AND 
“Prevalence”[MeSH] Limits: Humans, Journal Article, English
7
(“Prevalence”[MeSH]) AND systematic[sb] “Working group” Limits: English 15
[CN] Limits: Humans, Meta-Analysis, English, Core clinical journals 2
(“Prevalence”[MeSH]) AND systematic[sb] Limits: Humans, Meta-Analysis, English, Core clinical journals 
Moher D[author] 19
“Epidemiologic Studies”[MeSH] Limits: Humans, Meta-Analysis, English AND “Incidence”[MeSH] Limits: 
Humans, Meta-Analysis, English Limits: Humans, Meta-Analysis, English, Core clinical journals
57
“Epidemiologic Studies”[MeSH] AND “Incidence”[MeSH] Limits: Humans, Meta-Analysis, English 26
“Epidemiologic Studies”[MeSH] AND “Incidence”[MeSH] AND Evidence Limits: Humans, Meta-Analysis, 
English
52
“Incidence”[MeSH] Limits: Humans, Meta-Analysis, English 65
“Risk”[MeSH] AND “Epidemiologic Studies”[MeSH] Limits: Humans, Meta-Analysis, English, Core clinical 
journals
27
“Prevalence”[MeSH] Limits: Humans, Meta-Analysis, English, Core clinical journals 
Altman DG[author] 7
Higgins J[author] 
 
Abbreviations: MeSH, Medical Subject Heading term; sb, subset; CN, corporate author.
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Search Method No. of Articles Identified
MEDLINE search via PubMed (continued) 
“Review Literature as Topic”[MeSH] AND “Research Design/standards”[MeSH] AND “Epidemiologic 
Studies”[MeSH] Limits: Humans, English, Core clinical journals
0
“Review Literature as Topic”[MeSH] AND “Epidemiologic Studies”[MeSH] AND “Quality control”[MeSH] 1
“Incidence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Peer Review, Research”[MeSH] 
AND “Research Design/standards”[MeSH]
0
“Incidence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Peer Review, Research”[MeSH] 0
“Incidence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Research Design/
standards”[MeSH]
0
“Incidence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND (“Data Collection/methods”[MeSH] 
OR “Data Collection/standards”[MeSH])
5
“Incidence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Bias (Epidemiology)”[MeSH] 1
“Incidence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND (“Questionnaires/methods”[MeSH] 
OR “Questionnaires/standards”[MeSH])
0
“Incidence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Evidence-Based Medicine”[MeSH] 2
“Incidence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Reproducibility of Results”[MeSH] 
“Prevalence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Peer Review, Research”[MeSH] 
AND “Research Design/standards”[MeSH]
0
“Prevalence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Peer Review, Research”[MeSH] 0
“Prevalence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Research Design/
standards”[MeSH]
0
“Prevalence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND (“Data Collection/methods”[MeSH] 
OR “Data Collection/standards”[MeSH])
16
“Prevalence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Bias (Epidemiology)”[MeSH] 6
“Prevalence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND (“Questionnaires/methods”[MeSH] 
OR “Questionnaires/standards”[MeSH])
1
“Prevalence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Evidence-Based Medicine”[MeSH] 0
“Prevalence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Reproducibility of Results”[MeSH] 12
“Risk Factors”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Peer Review, Research”[MeSH] 
AND “Research Design/standards”[MeSH]
0
“Risk Factors”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Peer Review, Research”[MeSH] 0
“Risk Factors”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Research Design/
standards”[MeSH]
1
“Risk Factors”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND (“Data Collection/
methods”[MeSH] OR “Data Collection/standards”[MeSH])
1
 
Abbreviations: MeSH, Medical Subject Heading term; sb, subset; CN, corporate author.
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Search Method No. of Articles Identified
MEDLINE search via PubMed (continued)
“Risk Factors”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Bias (Epidemiology)”[MeSH] 7
“Risk Factors”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND (“Questionnaires/
methods”[MeSH] OR “Questionnaires/standards”[MeSH])
1
“Risk Factors”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Evidence-Based 
Medicine”[MeSH]

“Risk Factors”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND “Reproducibility of 
Results”[MeSH]
10
“Health Care Quality, Access, and Evaluation”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND 
“Peer Review, Research”[MeSH] AND “Research Design/standards”[MeSH]
0
“Health Care Quality, Access, and Evaluation”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND 
“Peer Review, Research”[MeSH]
0
“Health Care Quality, Access, and Evaluation”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND 
“Research Design/standards”[MeSH]

“Health Care Quality, Access, and Evaluation”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND 
“Evidence-Based Medicine”[MeSH]

“Health Care Quality, Access, and Evaluation”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND 
“Bias (Epidemiology)”[MeSH]

“Models, Statistical”[MeSH] AND “Risk Factors”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND 
“Research Design/standards”[MeSH]
0
“Models, Statistical”[MeSH] AND “Incidence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND 
“Research Design/standards”[MeSH]
0
“Models, Statistical”[MeSH] AND “Prevalence”[MeSH] AND “Chronic Disease/epidemiology”[MeSH] AND 
“Research Design/standards”[MeSH]
0
“Epidemiologic Studies”[MeSH] AND “Models, Statistical”[MeSH] AND “Research Design/
standards”[MeSH]
7
“Prevalence”[MeSH] AND “Epidemiologic Studies”[MeSH] AND “Models, Statistical”[MeSH] AND “Bias 
(Epidemiology)”[MeSH]
61
“Incidence”[MeSH] AND “Epidemiologic Studies”[MeSH] AND “Models, Statistical”[MeSH] AND “Bias 
(Epidemiology)”[MeSH]
66
“Research Design/standards”[MeSH] AND (“Biomedical Research/methods”[MeSH] OR “Biomedical 
Research/organization and administration”[MeSH] OR “Biomedical Research/standards”[MeSH] OR 
“Biomedical Research/statistics and numerical data”[MeSH] OR “Biomedical Research/trends”[MeSH]) 
Limits: Humans, Journal Article, English
62
 
Abbreviations: MeSH, Medical Subject Heading term; sb, subset; CN, corporate author.
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Table 2. Quality of Systematic Review and Meta-Analyses of Nontherapeutic Observational Studies Published in Core Clinical 
Journals, 1990 Through June 2008
Publication Characteristics Outcome Estimate
Assessment of Quality of 
Included Studies
Bracken, 1990 (32) 
Country: United States 
Journal: Obstet Gynecol 
Sponsorship: Not reported 
Conflict of interest (COI): Not reported 
Sponsor participation in data analyses: Not reported
Congenital malformations 
in offspring
Risk No
Romieu et al, 1990 (33) 
Country: United States 
Journal: Cancer 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Breast cancer Risk Quality criteria abstracted
Haughey et al, 1992 (34) 
Country: United States 
Journal: Ann Otol Rhinol Laryngol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Second malignant tumors 
in head and neck cancer
Risk No
Figure. Study flow to identify systematic reviews of observational studies, scales, and checklists 
for planned formal internal quality evaluation, and studies about bias in observational research, 
1990 through June 200.
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Publication Characteristics Outcome Estimate
Assessment of Quality of 
Included Studies
Lemon et al, 1992 (35) 
Country: United States 
Journal: Cancer 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Nonfamilial breast cancer Continuous variable No
McKenna, 1992 (36) 
Country: United Kingdom 
Journal: Am J Med 
Sponsorship: Nonprofit organization, nursing home 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Differences in vitamin D 
status
Prevalence Quality criteria abstracted
Morris et al, 1992 (37) 
Country: United States 
Journal: Am J Public Health 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Cancer Risk Yes
Myers and Basinski, 1992 (38) 
Country: Canada 
Journal: Arch Intern Med 
Sponsorship: Nonprofit organization, award 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary heart disease Risk No
Becker et al, 1993 (39) 
Country: United States 
Journal: Ann Emerg Med 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Survival of cardiac arrest Risk No
Brownson et al, 1993 (40) 
Country: United States 
Journal: Arch Intern Med 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Adult leukemia Risk Yes
Ernst and Resch, 1993 (41) 
Country: Austria 
Journal: Ann Intern Med 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Cardiovascular risk factor Risk No
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Publication Characteristics Outcome Estimate
Assessment of Quality of 
Included Studies
Katerndahl, 1993 (42) 
Country: United States 
Journal: J Nerv Ment Dis 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Panic disorder and mitral 
valve prolapse
Risk Yes
Harris and Barraclough, 1994 (43) 
Country: United Kingdom 
Journal: Medicine 
Sponsorship: Industry 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Suicide Risk No
Kawachi et al, 1994 (44) 
Country: United States 
Journal: Br Heart J 
Sponsorship: Industry, scholarship 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary heart disease Risk No
Law et al, 1994 (45) 
Country: United Kingdom 
Journal: BMJ 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Hazards of reducing serum 
cholesterol
Risk No
Law et al, 1994 (46) 
Country: United Kingdom 
Journal: BMJ 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Ischemic heart disease Risk No
Steffen et al, 1994 (47) 
Country: Switzerland 
Journal: JAMA 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Hepatitis A Risk No
Zhang and Begg, 1994 (48) 
Country: United States 
Journal: Int J Epidemiol 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Cervical neoplasia Risk No
Appendix Table 2. (continued) Quality of Systematic Review and Meta-Analyses of Nontherapeutic Observational Studies Published in 
Core Clinical Journals, 1990 Through June 2008
(Continued on next page)VOLUME 7: NO. 6
NOVEMBER 2010
  www.cdc.gov/pcd/issues/2010/nov/09_0195.htm • Centers for Disease Control and Prevention  25
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the US Department of Health and Human Services, the 
Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and 
does not imply endorsement by any of the groups named above.
Publication Characteristics Outcome Estimate
Assessment of Quality of 
Included Studies
Everhart and Wright, 1995 (49) 
Country: United States 
Journal: JAMA 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Pancreatic cancer Risk No
Feinberg et al, 1995 (50) 
Country: United States 
Journal: Arch Intern Med 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Atrial fibrillation Prevalence No
Ritchie and Kildea, 1995 (51) 
Country: France 
Journal: Lancet 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Senile dementia Prevalence No
Raman-Wilms et al, 1995 (52) 
Country: Canada 
Journal: Obstet Gynecol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Fetal genital effects Risk No
Hatsukami and Fischman, 1996 (53) 
Country: United States 
Journal: JAMA 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Use of crack cocaine and 
cocaine hydrochloride
Prevalence No
Hill and Schoener, 1996 (54) 
Country: United States 
Journal: Am J Psychiatry 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Attention deficit  
hyperactivity disorder
Prevalence No
Hackshaw et al, 1997 (55) 
Country: United Kingdom 
Journal: BMJ 
Sponsorship: Government 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: “The views expressed 
are those of the authors and not necessarily those of the 
Department of Health.”
Lung cancer Risk No
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Publication Characteristics Outcome Estimate
Assessment of Quality of 
Included Studies
Kluijtmans et al, 1997 (56) 
Country: Netherlands 
Journal: Circulation 
Sponsorship: Nonprofit organization, industry 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary artery disease Risk No
Law and Hackshaw, 1997 (57) 
Country: United Kingdom 
Journal: BMJ 
Sponsorship: None 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: None
Hip fracture Risk No
Law et al, 1997 (58) 
Country: United Kingdom 
Journal: BMJ 
Sponsorship: Government 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: “The Department of 
Health (England) supported this work, although the views are 
our own.”
Ischemic heart disease Risk No
Danesh et al, 1998 (59) 
Country: United Kingdom 
Journal: JAMA 
Sponsorship: Scholarship, nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary heart disease Risk Yes
French and Brocklehurst, 1998 (60) 
Country: United Kingdom 
Journal: Br J Obstet Gynaecol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Survival in women  
infected with human  
immunodeficiency virus
Risk Yes
Forgie et al, 1998 (61) 
Country: Canada 
Journal: Arch Intern Med 
Sponsorship: Industry, government, fellowships, nonprofit orga-
nization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Allogeneic blood  
transfusion
Risk No
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Publication Characteristics Outcome Estimate
Assessment of Quality of 
Included Studies
Huang et al, 1998 (62) 
Country: Canada 
Journal: Gastroenterology 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Gastric cancer Risk Yes
Johnston et al, 1998 (63) 
Country: United States 
Journal: Neurology 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Subarachnoid hemorrhage Risk No
Lazarou et al, 1998 (64) 
Country: Canada 
Journal: JAMA 
Sponsorship: Scholarship, nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Adverse drug reactions in 
hospitalized patients
Prevalence Quality criteria abstracted
Ray, 1998 (65) 
Country: Canada 
Journal: Arch Intern Med 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Venous thromboembolic 
disease
Risk Quality criteria abstracted
Spencer-Green, 1998 (66) 
Country: United States 
Journal: Arch Intern Med 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Secondary diseases  
from primary Reynaud  
phenomenon
Risk Yes
Stratton et al, 1998 (67) 
Country: United Kingdom 
Journal: Br J Obstet Gynaecol 
Sponsorship: Research fellowship, nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Ovarian cancer Risk No
Zock and Katan, 1998 (68) 
Country: Netherlands 
Journal: Am J Clin Nutr 
Sponsorship: Nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Breast, colorectal, and 
prostate cancer
Risk Quality criteria abstracted
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Publication Characteristics Outcome Estimate
Assessment of Quality of 
Included Studies
Zondervan et al, 1998 (69) 
Country: United Kingdom 
Journal: Br J Obstet Gynaecol 
Sponsorship: Nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Chronic pelvic pain in 
women
Prevalence No
Angelillo and Villari, 1999 (70) 
Country: Italy 
Journal: Bull World Health Organ 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Childhood leukemia Risk Yes
He et al, 1999 (71) 
Country: United States 
Journal: N Engl J Med 
Sponsorship: Nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary heart disease Risk No
Shaffer et al, 1999 (72) 
Country: United States 
Journal: Am J Public Health 
Sponsorship: Nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Disordered gambling 
behavior
Prevalence No
Wittrup et al, 1999 (73) 
Country: Denmark 
Journal: Circulation 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Ischemic heart disease Risk Yes
Yoder et al, 1999 (74) 
Country: United States 
Journal: Obstet Gynecol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Fetus with isolated choroid 
plexus cysts
Risk No
Christen et al, 2000 (75) 
Country: United States 
Journal: Arch Intern Med 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Cardiovascular disease Risk Yes
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Publication Characteristics Outcome Estimate
Assessment of Quality of 
Included Studies
Cleophas et al, 2000 (76) 
Country: Netherlands 
Journal: Am J Cardiol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary artery disease Risk Yes
DiMatteo et al, 2000 (77) 
Country: United States 
Journal: Arch Intern Med 
Sponsorship: Industry, scholarship 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Noncompliance with medi-
cal treatment
Risk Quality criteria abstracted
WHO Collaborative Study Team on the Role of Breastfeeding 
on the Prevention of Infant Mortality, 2000 (78) 
Country: Brazil 
Journal: Lancet 
Sponsorship: Nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Infant and child mortality Risk No
Wilson et al, 2000 (79) 
Country: Canada 
Journal: Arch Intern Med 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Mortality after myocardial 
infarction
Risk Yes
Zeegers et al, 2000 (80) 
Country: Netherlands 
Journal: Cancer 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Urinary tract cancer Risk Yes
Danesh et al, 2001 (81) 
Country: United Kingdom 
Journal: Circulation 
Sponsorship: Government, scholarship 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary heart disease Risk No
Eaden et al, 2001 (82) 
Country: United Kingdom 
Journal: Gut 
Sponsorship: Nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Colorectal cancer Risk Yes
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Publication Characteristics Outcome Estimate
Assessment of Quality of 
Included Studies
Faraone et al, 2001 (83) 
Country: United States 
Journal: Am J Psychiatry 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Attention deficit hyperactiv-
ity disorder
Risk Yes
Horta et al, 2001 (84) 
Country: Brazil 
Journal: Am J Public Health 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Early weaning Risk Yes
Rebora, 2001 (85) 
Country: Italy 
Journal: Arch Dermatol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary artery disease Risk Yes
Cannon et al, 2002 (86) 
Country: United Kingdom 
Journal: Am J Psychiatry 
Sponsorship: Research fellowship, nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Schizophrenia Risk No
Hellermann et al, 2002 (87) 
Country: United States 
Journal: Am J Med 
Sponsorship: Government, nonprofit organization, fellowship 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Heart failure Risk No
Huang et al, 2002 (88) 
Country: Canada 
Journal: Lancet 
Sponsorship: Not reported 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Peptic-ulcer disease Risk Yes
Huncharek et al, 2002 (89) 
Country: United States 
Journal: Am J Public Health 
Sponsorship: Nonprofit organization, industry 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Malignant melanoma Risk Yes
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Publication Characteristics Outcome Estimate
Assessment of Quality of 
Included Studies
Juul et al, 2002 (90) 
Country: Denmark 
Journal: Blood 
Sponsorship: Government, nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: “They had no role in 
gathering, analyzing, or interpreting the data and had no right 
to approve or disapprove the submitted paper.”
Factor V Leiden Risk Yes
Kelly et al, 2002 (91) 
Country: United States 
Journal: Neurology 
Sponsorship: Nonprofit organization, industry, fellowship 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Risk of ischemic stroke Risk No
Klerk et al, 2002 (92) 
Country: Netherlands 
Journal: JAMA 
Sponsorship: Government, “public/private partnership” 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary heart disease Risk Yes
Kozer et al, 2002 (93) 
Country: Canada 
Journal: Am J Obstet Gynecol 
Sponsorship: Industry 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Congenital anomalies Risk No
Law et al, 2002 (94) 
Country: United Kingdom 
Journal: Arch Intern Med 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Death after myocardial 
infarction
Risk No
Wald et al, 2002 (95) 
Country: United Kingdom 
Journal: BMJ 
Sponsorship: None 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: None
Cardiovascular disease Risk No
Wald and Link, 2002 (96) 
Country: United States 
Journal: J Infect Dis 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Human immunodeficiency 
virus infection
Risk No
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Benjamin et al, 2003 (97) 
Country: United States 
Journal: Pediatrics 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
End-organ damage Prevalence No
Clarfield, 2003 (98) 
Country: Israel 
Journal: Arch Intern Med 
Sponsorship: Not reported 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Reversible dementias Prevalence No
Cole and Dendukuri, 2003 (99) 
Country: Canada 
Journal: Am J Psychiatry 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Depression among elderly 
community subjects
Risk Yes
Gisbert et al, 2003 (100) 
Country: Spain 
Journal: Gastroenterology 
Sponsorship: Nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Hepatitis C virus infection Risk Yes
Glatt et al, 2003 (101) 
Country: United States 
Journal: Am J Psychiatry 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Schizophrenia Risk No
Halbert et al, 2003 (102) 
Country: United States 
Journal: Chest 
Sponsorship: Industry 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Prevalence estimates  
for chronic obstructive  
pulmonary disease
Prevalence No
Huang et al, 2003 (103) 
Country: Canada 
Journal: Gastroenterology 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Gastric cancer Risk Yes
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Rey et al, 2003 (104) 
Country: Canada 
Journal: Lancet 
Sponsorship: Government 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Fetal loss Risk Yes
Riboli and Norat, 2003 (105) 
Country: France 
Journal: Am J Clin Nutr 
Sponsorship: Government 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Cancer risk Risk No
Scholten-Peeters et al, 2003 (106) 
Country: Netherlands 
Journal: Pain 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Whiplash-associated  
disorders
Risk Yes
Thurnham et al, 2003 (107) 
Country: United Kingdom 
Journal: Lancet 
Sponsorship: Government, fellowship 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: “The funding source 
had no role in study design, data collection, data analysis, data 
interpretation, or in the writing of this report.”
Vitamin A deficiency Continuous variable No
Zeegers et al, 2003 (108) 
Country: Netherlands 
Journal: Cancer 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Prostate carcinoma Risk No
Burzotta et al, 2004 (109) 
Country: Italy 
Journal: Heart 
Sponsorship: Fellowship 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary ischemic 
syndromes
Risk No
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Casas et al, 2004 (110) 
Country: United Kingdom 
Journal: Circulation 
Sponsorship: Government, 1 author holds a chair of nonprofit 
organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Ischemic heart disease Risk No
Casas et al, 2004 (111) 
Country: United Kingdom 
Journal: Arch Neurol 
Sponsorship: Fellowship 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Ischemic stroke Risk No
He et al, 2004 (112) 
Country: United States 
Journal: Circulation 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary heart disease 
mortality
Risk No
Huang et al, 2004 (113) 
Country: United States 
Journal: Neurology 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Sporadic Parkinson  
disease
Risk No
Klement et al, 2004 (114) 
Country: Israel 
Journal: Am J Clin Nutr 
Sponsorship: Medical center 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Inflammatory bowel  
disease
Risk Yes
Kovalevsky et al, 2004 (115) 
Country: United States 
Journal: Arch Intern Med 
Sponsorship: Not reported 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Recurrent pregnancy loss Risk No
Levitan et al, 2004 (116) 
Country: United States 
Journal: Arch Intern Med 
Sponsorship: Not reported 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Cardiovascular disease Risk No
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Lovett et al, 2004 (117) 
Country: United Kingdom 
Journal: Neurology 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Subtype of ischemic stroke Risk Yes
Mitsikostas et al, 2004 (118) 
Country: Greece 
Journal: Brain 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Headache Risk No
Montanez et al, 2004 (119) 
Country: United States 
Journal: Arch Intern Med 
Sponsorship: Not reported 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Total and cardiovascular 
mortality and sudden death
Risk No
Woodbury and Houghton, 2004 (120) 
Country: Canada 
Journal: Ostomy Wound Manage 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Pressure ulcers Prevalence Yes
Bolland et al, 2005 (121) 
Country: New Zealand 
Journal: J Clin Endocrinol Metab 
Sponsorship: Scholarship 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Increased body weight Risk Quality criteria abstracted
Contopoulos-Ioannidis et al, 2005 (122) 
Country: Greece 
Journal: J Allergy Clin Immunol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Asthma phenotypes Risk Quality criteria abstracted
Dauchet et al, 2005 (123) 
Country: France 
Journal: Neurology 
Sponsorship: Nonprofit organization, educational institute 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Stroke Risk No
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Etminan et al, 2005 (124) 
Country: Canada 
Journal: BMJ 
Sponsorship: Government, fellowship 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Ischemic stroke Risk Yes
Fazel et al, 2005 (125) 
Country: United Kingdom 
Journal: Lancet 
Sponsorship: Nonprofit organization 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: “The sponsors of the 
study had no role in study design, data collection, data analy-
sis, data interpretation, or writing of the report. The correspond-
ing author had full access to all the data in the study and had 
final responsibility for the decision to submit for publication.”
Serious mental disorder Prevalence Quality criteria abstracted
García-Closas et al, 2005 (126) 
Country: United States 
Journal: Lancet 
Sponsorship: Nonprofit organization 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: “The study sponsors 
had no role in the design of the study; in the collection, analy-
sis, or interpretation of the data; or in the writing of the report. 
The corresponding author had full access to all the data in the 
study and had final responsibility for the decision to submit the 
paper for publication.”
Bladder cancer Risk No
Lee et al, 2005 (127) 
Country: United States 
Journal: Arthritis Rheum 
Sponsorship: Government, industry 
COI: Not reported 
Sponsor participation in data analyses: Unrestricted
Systemic lupus  
erythematosus
Risk No
Lin and August, 2005 (128) 
Country: United States 
Journal: Obstet Gynecol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Preeclampsia Risk No
McDonald et al, 2005 (129) 
Country: Canada 
Journal: Am J Obstet Gynecol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Perinatal outcomes Risk Yes
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Palmer, 2005 (130) 
Country: United States 
Journal: Arch Gen Psychiatry 
Sponsorship: Nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Lifetime risk of suicide in 
schizophrenia
Prevalence Quality criteria abstracted
Sin et al, 2005 (131) 
Country: Canada 
Journal: Chest 
Sponsorship: Nonprofit organization, educational institute 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Cardiovascular mortality Risk Yes
Boudville et al, 2006 (132) 
Country: Canada 
Journal: Ann Intern Med 
Sponsorship: Government, fellowship 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: “The study sponsors 
had no role in the study design; in the collection, analysis, and 
interpretation of data; in the writing of the report; or in the deci-
sion to submit the paper for publication.”
Hypertension Risk No
Clark et al, 2006 (133) 
Country: United Kingdom 
Journal: Pediatrics 
Sponsorship: Fellowship 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Fractures Risk Yes
de Boer et al, 2006 (134) 
Country: Netherlands 
Journal: Cancer 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Unemployment Risk Yes
Di Castelnuovo et al, 2006 (135) 
Country: Italy 
Journal: Arch Intern Med 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: “The sponsor of the 
study had no involvement in study design; data collection, anal-
ysis, or interpretation; writing of the report; or in the decision to 
submit the paper for publication.”
Total mortality in men and 
women
Risk Yes
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Flores-Mateo et al, 2006 (136) 
Country: United States 
Journal: Am J Clin Nutr 
Sponsorship: Nonprofit organization 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Coronary heart disease Risk Yes
Galassi et al, 2006 (137) 
Country: United States 
Journal: Am J Med 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Cardiovascular disease Risk Quality criteria abstracted
Huxley et al, 2006 (138) 
Country: Australia 
Journal: BMJ 
Sponsorship: Government, fellowship, industry 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Unconditional
Fatal coronary heart  
disease
Risk Quality criteria abstracted
Kahlenborn et al, 2006 (139) 
Country: United States 
Journal: Mayo Clin Proc 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Premenopausal breast 
cancer
Risk Quality criteria abstracted
Larsson et al, 2006 (140) 
Country: Sweden 
Journal: Gastroenterology 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Esophageal, gastric, and 
pancreatic cancer
Risk Quality criteria abstracted
Mahid et al, 2006 (141) 
Country: United States 
Journal: Mayo Clin Proc 
Sponsorship: Nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Inflammatory bowel  
disease
Risk Yes
Owen et al, 2006 (142) 
Country: United Kingdom 
Journal: Am J Clin Nutr 
Sponsorship: Nonprofit organization 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Type 2 diabetes Risk Quality criteria abstracted
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Ownby et al, 2006 (143) 
Country: United States 
Journal: Arch Gen Psychiatry 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Alzheimer disease Risk Yes
Pavia et al, 2006 (144) 
Country: Italy 
Journal: Am J Clin Nutr 
Sponsorship: Not reported 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Oral cancer Risk Yes
Riddle et al, 2006 (145) 
Country: United States 
Journal: Am J Trop Med Hyg 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Diarrhea Prevalence Yes
Rutledge et al, 2006 (146) 
Country: United States 
Journal: J Am Coll Cardiol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Depression Prevalence/risk Quality criteria abstracted
Smith et al, 2006 (147) 
Country: United States 
Journal: J Am Coll Cardiol 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Renal impairment Risk Yes
Weis et al, 2006 (148) 
Country: United States 
Journal: Arch Ophthalmol 
Sponsorship: Government 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Uveal melanoma Risk Quality criteria abstracted
Williams et al, 2006 (149) 
Country: United Kingdom 
Journal: Arch Dis Child 
Sponsorship: Nonprofit organization 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Autism spectrum disorders Prevalence/risk Quality criteria abstracted
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Bahekar et al, 2007 (150) 
Country: United States 
Journal: Am Heart J 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Coronary heart disease Risk Yes
Baurecht et al, 2007 (151) 
Country: Germany 
Journal: J Allergy Clin Immunol 
Sponsorship: Government, university 
COI: Reported as a conflict of interest 
Sponsor participation in data analyses: Not reported
Atopic eczema Risk No
Bellamy et al, 2007 (152) 
Country: United Kingdom 
Journal: BMJ 
Sponsorship: Government, fellowship 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Cardiovascular disease Risk Quality criteria abstracted
Conde-Agudelo et al, 2007 (153) 
Country: Colombia 
Journal: Am J Obstet Gynecol 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: “The content of the 
paper has not been influenced by the sponsor.”
Maternal health Risk Yes
Dehghan et al, 2007 (154) 
Country: Netherlands 
Journal: Diabetes 
Sponsorship: University, government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Diabetes Risk No
Eichler et al, 2007 (155) 
Country: Switzerland 
Journal: Am Heart J 
Sponsorship: Nonprofit organization 
COI: Not reported 
Sponsor participation in data analyses: “The funding source 
had no influence on study design; in the collection, analysis, 
and interpretation of the data; in the writing of the manuscript; 
and in the decision to submit the manuscript for publication.”
First coronary events Risk Yes
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Gami et al, 2007 (156) 
Country: United States 
Journal: J Am Coll Cardiol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Cardiovascular events and 
death
Risk Yes
Grulich et al, 2007 (157) 
Country: Australia 
Journal: Lancet 
Sponsorship: Government, fellowship, scholarship 
COI: Reported as a conflict of interest 
Sponsor participation in data analyses: “There was no funding 
source for this study. All authors had access to all the data. The 
corresponding author had final responsibility for the decision to 
submit for publication.”
Cancers Risk Yes
Havemann et al, 2007 (158) 
Country: United States 
Journal: Gut 
Sponsorship: Industry 
COI: Reported as a conflict of interest 
Sponsor participation in data analyses: Not reported
Asthma Risk Quality criteria abstracted
Hirtz et al, 2007 (159) 
Country: United States 
Journal: Neurology 
Sponsorship: Not reported 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Common neurologic  
disorders
Prevalence Yes
Huxley et al, 2007 (160) 
Country: Australia 
Journal: Am J Clin Nutr 
Sponsorship: Government, nonprofit organization 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: “None of the funding 
sources had any role in the study design, data analysis, data 
interpretation, writing of the paper, or the decision to submit 
the paper for publication.”
Ischemic heart disease Risk Yes
Krishna and Kim, 2007 (161) 
Country: United States 
Journal: J Neurosurg 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Risk factors for subarach-
noid hemorrhage
Risk Quality criteria abstracted
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Langan et al, 2007 (162) 
Country: United Kingdom 
Journal: Arch Dermatol 
Sponsorship: Nonprofit organization 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: “The sponsor had 
no role in the design and conduct of the study; in the collec-
tion, analysis, and interpretation of data; or in the preparation, 
review, or approval of the manuscript.”
Eczema Risk Quality criteria abstracted
Larsson and Wolk, 2007 (163) 
Country: Sweden 
Journal: Am J Clin Nutr 
Sponsorship: Nonprofit organization 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Colon and rectal cancer 
risk
Risk Quality criteria abstracted
Larsson and Wolk, 2007 (164) 
Country: Sweden 
Journal: Gastroenterology 
Sponsorship: Nonprofit organization 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: “The sponsor had no 
role in the study design or in the collection, analysis, and inter-
pretation of the data.”
Liver cancer Risk Quality criteria abstracted
Liu et al, 2007 (165) 
Country: China 
Journal: J Am Coll Cardiol 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Recurrence of atrial fibrilla-
tion after successful elec-
trical cardioversion
Risk Yes
Loza and Chang, 2007 (166) 
Country: United States 
Journal: J Allergy Clin Immunol 
Sponsorship: Government, nonprofit organization 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Atopic asthma risk Risk Yes
Pittas et al, 2007 (167) 
Country: United States 
Journal: J Clin Endocrinol Metab 
Sponsorship: Government 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Type 2 diabetes Risk No
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Polanczyk et al, 2007 (168) 
Country: Brazil 
Journal: Am J Psychiatry 
Sponsorship: Industry, foreign grants 
COI: Not reported 
Sponsor participation in data analyses: “There was no involve-
ment of any funding source in the study design, data collection, 
analysis, interpretation of data, and writing of this article or in 
the decision to submit the article for publication.”
Attention deficit hyperactiv-
ity disorder
Prevalence No
Rona et al, 2007 (169) 
Country: United Kingdom 
Journal: J Allergy Clin Immunol 
Sponsorship: Government 
COI: Reported as a conflict of interest 
Sponsor participation in data analyses: Not reported
Food allergy Prevalence Quality criteria abstracted
Sarwar et al, 2007 (170) 
Country: United Kingdom 
Journal: Circulation 
Sponsorship: Government, scholarship, industry 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Unrestricted
Coronary heart disease Risk No
Snoep et al, 2007 (171) 
Country: Netherlands 
Journal: Am Heart J 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Clopidogrel nonresponsive-
ness
Prevalence Yes
Zintzaras and Kaditis, 2007 (172) 
Country: Greece 
Journal: Arch Pediatr Adolesc Med 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Blood pressure Risk Yes
Ageno et al, 2008 (173) 
Country: Italy 
Journal: Circulation 
Sponsorship: Not reported 
COI: Not reported 
Sponsor participation in data analyses: Not reported
Venous thromboembolism Risk Yes
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Publication Characteristics Outcome Estimate
Assessment of Quality of 
Included Studies
Barclay et al, 2008 (174) 
Country: Australia 
Journal: Am J Clin Nutr 
Sponsorship: Government 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Chronic disease risk Risk Quality criteria abstracted
Conde-Agudelo et al, 2008 (175) 
Country: United States 
Journal: Am J Obstet Gynecol 
Sponsorship: Government 
COI: Not reported 
Sponsor participation in data analyses: “The views expressed 
in this document are solely the responsibility of the authors 
and do not necessarily represent the views of the World Health 
Organization.”
Risk of preeclampsia Risk Yes
Schunkert et al, 2008 (176) 
Country: Germany 
Journal: Circulation 
Sponsorship: Government 
COI: Reported as not a conflict of interest 
Sponsor participation in data analyses: Not reported
Coronary artery disease Risk No
Appendix Table 2. (continued) Quality of Systematic Review and Meta-Analyses of Nontherapeutic Observational Studies Published in 
Core Clinical Journals, 1990 Through June 2008